Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
PDS Biotechnology Corp (EDGE)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/17/2023 |
4
| Freitag Gregory Gene (Director) has filed a Form 4 on PDS Biotechnology Corp|
Txns:
| Granted 9,000 options to buy
@ $5.13, valued at
$46.2k
|
|
| 07/17/2023 |
4
| BRAWLEY OTIS W (Director) has filed a Form 4 on PDS Biotechnology Corp|
Txns:
| Granted 9,000 options to buy
@ $5.13, valued at
$46.2k
|
|
| 07/17/2023 |
4
| Ali-Jackson Kamil (Director) has filed a Form 4 on PDS Biotechnology Corp|
Txns:
| Granted 9,000 options to buy
@ $5.13, valued at
$46.2k
|
|
| 07/17/2023 |
4
| SYKES RICHARD (Director) has filed a Form 4 on PDS Biotechnology Corp|
Txns:
| Granted 9,000 options to buy
@ $5.13, valued at
$46.2k
|
|
| 07/17/2023 |
4
| Glover Stephen C. (Director) has filed a Form 4 on PDS Biotechnology Corp|
Txns:
| Granted 9,000 options to buy
@ $5.13, valued at
$46.2k
|
|
| 07/17/2023 |
4
| Iliev Ilian (Director) has filed a Form 4 on PDS Biotechnology Corp|
Txns:
| Granted 9,000 options to buy
@ $5.13, valued at
$46.2k
|
|
| 01/06/2023 |
4
| Brown Spencer D. (Senior VP, General Counsel) has filed a Form 4 on PDS Biotechnology Corp|
Txns:
| Granted 20,400 options to buy
@ $11.61, valued at
$236.8k
|
|
| 01/06/2023 |
4
| HILL MATTHEW C (CFO) has filed a Form 4 on PDS Biotechnology Corp|
Txns:
| Granted 161,200 options to buy
@ $11.61, valued at
$1.9M
|
|
| 01/06/2023 |
4
| CONN GREGORY (Chief Scientific Officer) has filed a Form 4 on PDS Biotechnology Corp|
Txns:
| Granted 137,200 options to buy
@ $11.61, valued at
$1.6M
|
|
| 01/06/2023 |
4
| BEDU-ADDO FRANK (President/CEO) has filed a Form 4 on PDS Biotechnology Corp|
Txns:
| Granted 385,300 options to buy
@ $11.61, valued at
$4.5M
|
|
| 01/06/2023 |
4
| WOOD LAUREN (Chief Medical Officer) has filed a Form 4 on PDS Biotechnology Corp|
Txns:
| Granted 110,800 options to buy
@ $11.61, valued at
$1.3M
|
|
| 12/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2022 |
4
| Glover Steve C (Director) has filed a Form 4 on PDS Biotechnology Corp|
Txns:
| Granted 9,000 options to buy
@ $3.9, valued at
$35.1k
|
|
| 06/29/2022 |
4
| Iliev Ilian (Director) has filed a Form 4 on PDS Biotechnology Corp|
Txns:
| Granted 9,000 options to buy
@ $3.9, valued at
$35.1k
|
|
| 06/29/2022 |
4
| BRAWLEY OTIS W (Director) has filed a Form 4 on PDS Biotechnology Corp|
Txns:
| Granted 9,000 options to buy
@ $3.9, valued at
$35.1k
|
|
| 06/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2022 |
4
| SYKES RICHARD (Director) has filed a Form 4 on PDS Biotechnology Corp|
Txns:
| Granted 9,000 options to buy
@ $3.9, valued at
$35.1k
|
|
| 06/29/2022 |
4
| Ali-Jackson Kamil (Director) has filed a Form 4 on PDS Biotechnology Corp|
Txns:
| Granted 9,000 options to buy
@ $3.9, valued at
$35.1k
|
|
| 06/03/2022 |
4
| Brown Spencer D. (Senior VP, General Counsel) has filed a Form 4 on PDS Biotechnology Corp|
Txns:
| Granted 150,000 options to buy
@ $4.22, valued at
$633k
|
|
| 01/20/2022 |
4
| CONN GREGORY (Chief Scientific Officer) has filed a Form 4 on PDS Biotechnology Corp|
Txns:
| Granted 112,100 options to buy
@ $6.28, valued at
$704k
|
|
| 01/20/2022 |
4
| BEDU-ADDO FRANK (President/CEO) has filed a Form 4 on PDS Biotechnology Corp|
Txns:
| Granted 291,500 options to buy
@ $6.28, valued at
$1.8M
|
|
| 01/20/2022 |
4
| WOOD LAUREN (Chief Medical Officer) has filed a Form 4 on PDS Biotechnology Corp|
Txns:
| Granted 88,600 options to buy
@ $6.28, valued at
$556.4k
|
|
| 12/14/2021 |
4
| HILL MATTHEW C (CFO) has filed a Form 4 on PDS Biotechnology Corp|
Txns:
| Bought 2,500 shares
@ $9, valued at
$22.5k
Bought 400 shares
@ $8.9, valued at
$3.6k
Bought 100 shares
@ $9, valued at
$900 |
|
| 10/20/2021 |
4
| HILL MATTHEW C (CFO) has filed a Form 4 on PDS Biotechnology Corp|
Txns:
| Granted 202,800 options to buy
@ $12.03, valued at
$2.4M
|
|
| 06/21/2021 |
4
| Bloomquist DeLyle W (See Remarks) has filed a Form 4 on PDS Biotechnology Corp|
Txns:
| Bought 10,000 shares
@ $9.8778, valued at
$98.8k
Exercised 2,970 options to buy
@ $5.99, valued at
$17.8k
|
|
| 06/17/2021 |
4
| BEDU-ADDO FRANK (President/CEO) has filed a Form 4 on PDS Biotechnology Corp|
Txns:
| Paid exercise price by delivering 27,166 shares
@ $12.86, valued at
$349.4k
Exercised 53,174 options to buy
@ $6.57, valued at
$349.4k
|
|
| 06/17/2021 |
4
| BRAWLEY OTIS W (Director) has filed a Form 4 on PDS Biotechnology Corp|
Txns:
| Granted 9,000 options to buy
@ $9.95, valued at
$89.6k
|
|
| 06/17/2021 |
4
| Glover Steve C (Director) has filed a Form 4 on PDS Biotechnology Corp|
Txns:
| Bought 5,882 shares
@ $8.5, valued at
$50k
Granted 9,000 options to buy
@ $9.95, valued at
$89.6k
|
|
| 06/17/2021 |
4
| Ali-Jackson Kamil (Director) has filed a Form 4 on PDS Biotechnology Corp|
Txns:
| Bought 11,764 shares
@ $8.5, valued at
$100k
Granted 9,000 options to buy
@ $9.95, valued at
$89.6k
|
|
| 06/17/2021 |
4
| SYKES RICHARD (Director) has filed a Form 4 on PDS Biotechnology Corp|
Txns:
| Granted 9,000 options to buy
@ $9.95, valued at
$89.6k
|
|
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2021 |
4
| VAN VOORHEES SETH (CFO) has filed a Form 4 on PDS Biotechnology Corp|
Txns:
| Bought 17,647 shares
@ $8.5, valued at
$150k
|
|
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2021 |
4
| VAN VOORHEES SETH (CFO) has filed a Form 4 on PDS Biotechnology Corp|
Txns:
| Granted 202,800 options to buy
@ $2.28, valued at
$462.4k
|
|
|
|
|